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TITLE OF CASE Do not include “a case report” 
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Abbreviations: EGJ: Esophagogastral junction, endoFLIP: endoluminal Functional 
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SUMMARY Up to 150 words summarising the case presentation and outcome (this 
will be freely available online) 
 
Here we present a case of a 50-year-old gentleman with a history of a Guillain-Barré-
Syndrome, who was referred to our clinic with recurrent esophageal candidiasis and 
longstanding intermittent retrosternal cramps for further evaluation. Other symptoms 
such as dysphagia, regurgitations and weight loss were denied and prior repeated 
endoscopy was otherwise unremarkable. Using high resolution impedance manometry, 
we could demonstrate a panesophageal pressure increase upon water swallows and 
complete aperistalsis of the tubular esophagus, indicating achalasia type II. However, 
due to the patient’s extraordinary body height and resulting length of the esophagus, 
endoFLIP analysis supplementary to high resolution impedance manometry needed to 
be used to assess distensibility of the esophagogastral junction and to secure the 
diagnosis of achalasia before appropriately treating the patient with pneumatic dilation. 
 
BACKGROUND Also describe why you think this case is important – why did you 
write it up? 
 
Achalasia is a rare esophageal motility disorder characterized by aperistalsis and 
impaired relaxation of the lower esophageal sphincter (LES). The incidence of the 
disorder is estimated to be about 1.6 cases and prevalence about 10 cases per 100.000 
population[1, 2]. The major clinical manifestations include dysphagia for both liquids and 
solids, retrosternal pain as well as instantaneous regurgitations upon deglutition and 
may be complicated by progressive weight loss[3]. Achalasia is caused by 
neurodegeneration of ganglion cells along the wall of the esophagus and the region of 
the LES, which is associated with inflammatory and fibrotic changes. Viral infections 
such as Herpes Simplex or Varicella Zoster triggering autoimmune processes are 
currently considered as the potential underlying pathogenesis of the disease[4-6]. 
Various autoimmune disorders such as Sjoegren Syndrome, Systemic Lupus or 
Rheumathoid Arthritis have all been associated with achalasia[7].  
The gold standard in diagnosing achalasia is esophageal manometry, detecting 
functional obstruction at the level of the LES and aperistalsis of the esophageal body[8]. 
Recently, the endoluminal functional lumen imaging probe (endoFLIP) emerged as a 
new diagnostic modality, which measures the distensibility as well as the opening 
dynamics of the esophagogastral junction (EGJ). However, due to a current lack of data 
supporting its utility as well as a paucity of standardized protocols, its clinical relevance 
in large patient sets is yet to be confirmed[9].  
Here we present a patient with history of a Guillain-Barré-Syndrome (GBS) developing 
achalasia with an atypical and unusual symptomatology. 
 
CASE PRESENTATION Presenting features, medical/social/family history 
 
A 50-year-old 7 feet tall male was referred to our clinic with a history of recurrent 
esophageal candidiasis and progressive intermittent retrosternal cramps. The patient 
reported a history of GBS without respiratory insufficiency at age 18 and 38. At age 42, 
the patient developed intermittent periods of retrosternal cramps predominantly at night 
and independently of physical exertion or food intake. Dysphagia, regurgitations, 
heartburn, reflux symptoms and weight loss were denied. An extensive cardiologic 
workup showed an asymptomatic LAD stenosis without evidence of myocardial 
ischemia. Upper endoscopy was unremarkable except esophageal candidiasis, which 
was treated with fluconazole. Subsequent HIV testing showed a negative result. The 
patient’s condition did not improve and the patient was repeatedly (age 45, 47, 49) 
scoped. Again, each time an esophageal candidiasis was found and treated with 
fluconazole, however without achieving relevant symptom amelioration. Due to 
recurrence of fungal infections of the esophagus, rare immunological disorders were 
ruled out with appropriate work up.   
INVESTIGATIONS If relevant 
 
After referral to our clinic, we performed esophageal high resolution impedance 
manometry (HRIM) to assess a possible esophageal motor dysfunction. HRIM 
demonstrated complete aperistalsis and panesophageal pressure increase upon 
standardized assessment with single swallows as well as insufficient esophageal 
clearance, as assessed by impedance measurements during a provocation 200g rice 
meal (Fig. 1). Due to the extraordinary body height and the resulting length of the 
esophagus, our manometry catheter was too short to completely cover the tubular 
esophagus and LES and hence accurately determine the integrated relaxation pressure. 
Bolus stasis was imminent on impedance testing. A complementary endoFLIP analysis 
verified restricted and pathologic distensibility of the EGJ of 2.1 mm2/ mmHg (Fig. 2 A). 
Compatible with these results a Barium swallow demonstrated stagnant contrast 
medium column in the distal esophagus after 1, 3 and 5 minutes (Fig.3 A). 
 
DIFFERENTIAL DIAGNOSIS If relevant 
 
TREATMENT and OUTCOME If relevant  
 
Based on the results that suggest the presence of achalasia type II, the therapeutic 
options were presented to the patient. Upon request, we performed a pneumatic 
dilation. At first, we used a 30mm Rigiflex balloon dilating the EGJ for 1 minute with 20 
PSI under fluoroscopic control to minimize the risk for esophageal perforation followed 
by a 35mm Rigiflex balloon dilation 3 months later. Progress monitoring with a barium 
swallow and improvement of the Eckardt score confirmed the successful intervention 
(Fig. 3 B, Table 1). Moreover, during the second dilation, no more esophageal 
candidiasis was observed.  
 
 
Weight 
loss (kg) Dysphagia 
Retrosternal 
pain Regurgitation 
Total 
score 
Before first 
dilation 0 0 3 0 3 
After sec. 
Dilation 0 0 1 0 1 
Table 1: Eckardt score before and after dilation treatment 
OUTCOME AND FOLLOW-UP   
 
In a 2 month follow up, the patient was doing significantly better and only complained of 
infrequent retrosternal cramps of mild intensity and an occasional feeling of a slow 
passage of food through the esophagus. Subjectively, the patient described an 80 – 
90% improvement of symptom severity. Follow up by symptom assessment and barium 
swallow is planned in 12 months.  
 
DISCUSSION Include a very brief review of similar published cases  
 
The above described case of achalasia is in several ways remarkable: At first, our 
patient has a history of GBS. After an extensive literature review we could find 3 cases 
reporting onset of achalasia with or after the development of a GBS[10-12]. A common 
pathogenesis or a causal relationship, however, remains to be elucidated.  
Both diseases are rare and a concomitant appearance in one individual patient 
estimated to be unlikely[12]. Mechanistically, a common autoimmune mechanism, 
potentially triggered by a gastroenteritis or respiratory tract infection is discussed as 
trigger in the literature[10-13]. In our case, there was a long duration of approximately 4 
years between the GBS and the onset of the first symptoms of achalasia. This could be 
presumably explained by a very slow disease progression with relatively mild 
symptoms, which remained atypical until our diagnosis 12 years later. Further, purely 
speculative and without any literature data, a “late onset GBS associated achalasia” 
could be proposed in our patient.     
Secondly, the patient presented with unusual symptomatology: The major complaint 
was an intermittent feeling of retrosternal cramps for years mainly independent of food 
intake and accompanied with recurrent esophageal candidiasis. There were no other 
classical symptoms of achalasia such as dysphagia, regurgitation or weight loss 
reported. This proved to be of relevance in two ways. On the one hand, the atypical 
presentation can be considered accountable for the long duration of about 7 years with 
numerous diagnostic workups till the correct diagnosis was finally made. It clearly 
demonstrates, that achalasia should be considered as a rare differential diagnosis of 
recurrent esophageal candidiasis with retrosternal cramps. Furthermore, it is interesting 
to note here that the esophageal candidiasis completely vanished after the dilation 
treatment making it likely that the candidiasis was caused by the persistent esophageal 
stasis associated with the impaired relaxation of the lower esophageal sphincter. On the 
other hand the atypical symptomatology showed that the Eckardt Score, which has so 
far been established as a useful disease severity scoring tool[14], does have certain 
limitations especially if atypical symptomatology of achalasia results in a very low initial 
score. This makes usage of the Eckardt score also problematic if monitoring of 
therapeutic success is intended (table 1).  
Thirdly, due to the patient’s extraordinary body height and the resulting length of the 
esophagus, the HRIM catheter was too short to fully cover the LES region. Hence, apart 
from aperistalsis and panesophageal pressure increase upon swallowing other 
parameters, such as the IRP, could not be precisely determined. However, according to 
current classification, the diagnosis of achalasia requires the detection of complete 
aperistalsis along with impaired deglutitive relaxation of the LES with an IRP > 15 
mmHg[8]. By using the endoFLIP technology as a supplementary tool we could further 
evaluate the EGJ and by detecting a pathologic distensibility secure the diagnosis (Fig. 
2A). In comparison, a normal distensibility of the EGJ can be observed in a healthy 
esophagus (Fig. 2B). This demonstrate that endoFLIP is a powerful supplementary tool 
to further characterize esophageal motility disorders especially in cases where technical 
limitations of HRIM hamper a correct diagnosis.   
 
LEARNING POINTS/TAKE HOME MESSAGES 3 to 5 bullet points – this is a required 
field 
 
• The pathogenesis of the Guillain-Barré-Syndrome and achalasia might share 
common autoimmune and neurodegenerative processes  
 
• Achalasia should be considered as a rare differential diagnosis in recurrent 
esophageal candidiasis 
 
• In achalasia with asymptomatic presentation, the Eckardt Score might be an 
insufficient tool in assessing disease severity and in monitoring the treatment 
success  
 
• EndoFLIP is a novel and useful tool to evaluate the distensibility of the EGJ 
especially in cases where HRIM does not show clear results or where the HRIM 
catheter is not well tolerated.   
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FIGURE/VIDEO CAPTIONS figures should NOT be embedded in this document 
 
Fig. 1: A) HRIM Clouse plot showing aperistalsis and panesophageal pressure increase 
instantaneously upon water swallows. Due to the significant length of the esophagus, 
both esophageal sphincters cannot be completely covered by the catheter. Hence 
important HRIM parameters such as the IRP could not be precisely determined. B) 
Combined HRIM Clouse and impediance plot showing aperistalsis and ineffective 
clearance during the rice meal.  
Fig. 2: A) EndoFLIP analysis showing a restricted and pathologic distensibility of the 
EGJ. B) In Comparison, a non-pathologic distensibility of a normal EGJ.  
Fig. 3: A) Barium swallows showing an impaired relaxation of the LES as well as a 
stagnant contrast medium column in the distal esophageus after 5 minutes B) After the 
second dilation a significantly improved passage of the contrast medium through the 
EGJ and no stagnant column after 5 minutes could be observed.  
 
PATIENT’S PERSPECTIVE Optional but strongly encouraged – this has to be written 
by the patient or next of kin 
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